Please login to the form below

Not currently logged in
Email:
Password:

Generic drug pricing

This page shows the latest Generic drug pricing news and features for those working in and with pharma, biotech and healthcare.

Teva among generic drugmakers hoping to settle US antitrust probe

Teva among generic drugmakers hoping to settle US antitrust probe

The DoJ claims that the accused generic drug makers colluded to maintain high prices of widely-prescribed drugs for more than five years, which cost federal health programmes billions of dollars. ... Back in  August, US politicians also accused Teva,

Latest news

  • Gottlieb signs off with flair – and pledge of further drug price commentary Gottlieb signs off with flair – and pledge of further drug price commentary

    This was based on Gottlieb’s bold approach to addressing unnecessary barriers to innovative medicines approvals, while at the same time tackling bottlenecks in generic drug approvals and pricing and competition ... This would once have been a radical

  • Trump budget targets rebates, out-of-pocket costs Trump budget targets rebates, out-of-pocket costs

    Away from drug pricing, the budget includes an increase in funding for HIV programmes, a 12.6% drop in funding for the National Institutes of Health (NIH) which is likely to ... The budget would fundamentally upset the successful Medicare drug benefit

  • Clinton takes aim at pharma pricing once again Clinton takes aim at pharma pricing once again

    It's wrong when drug companies put profits ahead of patients, with unjustified price increases not for new innovations, but for long-available and generic treatments," Clinton asserted. ... drug costs, and ensuring drug companies invest in research and

  • FDA allows accelerated review for rivals to over-priced drugs FDA allows accelerated review for rivals to over-priced drugs

    Aims to combat growing trend in exploitation of sole-source drug pricing. ... The US regulator has come in for its own share of criticism over drug pricing, defending itself from allegations that a backlog of generic drug applications was in part

  • Skin Deep

    However, increased competition from generic drug manufacturers, pricing pressures from Asian medicine producers and R&D expenses that can be anything upwards of $1.5bn are tightening the thumbscrews on the ... The crucial factor is gaining trust through

More from news
Approximately 1 fully matching, plus 5 partially matching documents found.

Latest Intelligence

  • Social media and inflation penalties for generic drugs Social media and inflation penalties for generic drugs

    US generic drug companies are under more scrutiny as the US public becomes more vocal . ... In response, companies must become more aware of and sensitive to community sentiment surrounding drug pricing.

  • Interview: Beate Wieseler, IQWIG Interview: Beate Wieseler, IQWIG

    The impact of AMNOG drug pricing. The main reason for the introduction of AMNOG was to reduce drug spend, according to Dr Wieseler. ... That is still open.”. IQWiG and clinical trial transparency. In addition to its role in German drug pricing, IQWiG

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Apex.co.uk Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...

Latest intelligence

Improve clinical trials through patient journey mapping
Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...
InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...

Infographics